(Q37618805)

21 August 2017

1 reference

title

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis (English)

1 reference

21 August 2017

0 references

mesenchymal stem cell

1 reference

1 reference

2

Ahmed Al-Qahtani

1 reference

21 August 2017

Vladislav Volarevic

1

1 reference

21 August 2017

Nebojsa Arsenijevic

series ordinal

3

1 reference

21 August 2017

Sladjana Pajovic

series ordinal

4

1 reference

21 August 2017

Miodrag L Lukic

series ordinal

5

1 reference

21 August 2017

publication date

1 June 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

43

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

255-263

1 reference

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Diabetes Treatment — Bridging the Divide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Investigation of the cause of death in a gene-therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Cytokines and beta-cell biology: from concept to clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Increased number of islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Adult mesenchymal stem cells: a pluripotent population with multiple applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Mesenchymal stromal cells from umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Mesenchymal stem cells avoid allogeneic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Immature, but not inactive: the tolerogenic function of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Potential risks of bone marrow cell transplantation into infarcted hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Opportunities and challenges for mesenchymal stem cell-mediated heart repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903305641

10.3109/08916930903305641

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference